Skip Navigation

Advertise|Press|Contact|FAQ|CWConnect

Bookmark/Print/Share

Home » Clinical Trials » Therapeutic Areas
Therapeutic Areas: Oncology | Immunology | Hematology
Disease Category: Non-Hodgkin's Lymphoma
Location: United States, WV

Clinical Trial Details

Overview

Research Study Summary

C14012 - A Phase 3, Randomized, Two-Arm, Open Label, Multicenter, International Trial of Alisertib or Investigator choice in Patients with Relapsed or Refractory Peripheral T-Cell Lymphoma

Purpose

Objectives: To determine if aliserib improves overall response rate, complete response rate and unconfirmed complete response rate plus partial response rate versus a selection of single agents in patients with relapsed or refractory T-cell lymphoma.

To Learn more
Phase

3

Gender

Both Male and Female

Age

N/A

Overall Status

Recruiting

Facility Type

N/A

Contact

West Virginia University - Clinical Trials Research Unit
Located In:
Morgantown, WV 26506

View Map

CW ID: 181826

Date Last Changed: July 18, 2013


DISCLAIMER: This site is run by CenterWatch, a publishing company that focuses on the clinical trials industry. The information provided in this service is designed to help patients find clinical trials that may be of interest to them, and to help patients contact the centers conducting the research. CenterWatch is neither promoting this research nor involved in conducting any of these trials.